CFNZ has submitted an application to Pharmac for the funding of the TOBI Podhaler device.
This device is similar to an asthma inhaler and delivers tobramycin in around 1 minute compared to about 20mins on a conventional nebuliser. This would make a dramatic difference to the lives of people with Pseudomonas infections.
We are extremely thankful for the expert help we received filling out this application and the strong letters of support from the CF community.
We had hoped that Pharmac's PTAC committee would add it to their minutes for their next meeting in May. This week Pharmac emailed Jane Bollard to say they have reviewed it according to their funding application guidelines and are planning to seek clinical advice from the Respiratory Subcommittee at their next meeting.
Pharmac staff also want to discuss the application with us.
We will keep you informed about any progress.